CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A

Overview of attention for article published in Journal of Hematology & Oncology, August 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (66th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Readers on

mendeley: 7 Mendeley

So far, Altmetric has seen 6 X posts from 5 X users, with an upper bound of 28,529 followers.

CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A. https://t.co/okKJ8pim67

Dr. Stanchina took great initiative to lead this study as a resident @MountSinaiNYC while rotating @sloan_kettering and will now be doing Hem/Onc fellowship @SylvesterCancer - congrats Michele! #leusm #MedTwitter #sciencetwitter

RT @msm_msw: Excellent article by Dr. Michelle Stanchina “CD33 splice site genotype was not associated with outcomes of patients receiving…

Excellent article by Dr. Michelle Stanchina “CD33 splice site genotype was not associated with outcomes of patients receiving anti-CD33 drug conjugate SGN-CD33A” @TaylorJ_MD @MountSinaiNYC @DOMSinaiNYC @slrchiefs @sloan_kettering @ASH_hematology @ASCO ht…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.